Hong Kong tips off Vietnam about contaminated GSK drug

Just days after ordering one importer to suspend sales of a drug and another to withdraw a drug from the market, Vietnamese officials now seek samples of the GlaxoSmithKline ($GSK) pediatric antibiotic Augmentin for precautionary testing. The Drug Administration of Vietnam has asked GSK to collect samples for testing following discovery of a plasticizer in Augmentin products distributed in Hong Kong.

Testing will focus on the levels of diisodecyl phthalate (DIDP), di-ethylhexyl phthalates, and other derivatives. In Hong Kong, officials said they detected DIDP in Augmentin tablets at a level twice as high as Europe's limit for the chemical in food contact materials.

Last month, plasticizer detected in a pediatric antibiotic manufactured by GSK in France led to a government-ordered recall by the drug giant.

The Vietnamese product test results are expected by August 5, 2011.

- read the story
- here's more

Suggested Articles

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot. 

The FDA recently asked five drug manufacturers to recall the commonly used diabetes med metformin. With COVID-19 raging, is metformin just the start?

The antidepressant Zoloft and its generics are in short supply as the COVID-19 pandemic has caused higher demand and manufacturing interruptions.